Acute rejection (AR) is a process triggered via the recognition of grafted organ-derived antigens by the immune system, which could present as a life-threatening condition. In the context of a kidney
In allograft monitoring of solid organ transplant recipients, liquid biopsy has emerged as a novel approach using quantification of donor-derived cell-free DNA (dd-cfDNA) in plasma. Despite early clin
0 = none detected.+ = very mild/mild – occasional events detected, 1–2 per field of view.++ = moderate – more than occasional, multiple events per field of view.+++ = severe – dominant phenotype, most